Apremilast
A phthalimide derivative that acts as a phosphodiesterase inhibitor (PDE-4 inhibitor), Apremilast is used for medium to severe chornic plaque psoriasis and psoriasis arthritis. It was approved for use in the US in 2014 and the EU in 2015.
Formula: C22H24N2O7S
Molecular weight: 460.00 g/mol
Molecular size: Small
Controlled Substance: No
Precursor: No
Indications: Immunosuppressants drugs
Status: In Development
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827